Skip to main content

Advertisement

SpringerLink
Log in

Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Messori A, Hyeraci G (2023) Meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data. Ann Hematol 1:1–3

    Google Scholar 

  2. Masetti R, Muratore E, Gori D, Prete A, Locatelli F (2022) Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis. Ann Hematol 101(11):2497–2506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zama D et al (2021) Enteral versus parenteral nutrition as nutritional support after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transplant Cell Ther 27(180):e1-180.e8

    Google Scholar 

  4. Ponvilawan B, Kungwankiattichai S, Charoenngam N, Owattanapanich W (2021) Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy? A systematic review and meta-analysis. PLoS One 16(6):e0253896

  5. Holtick U et al (2014) Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev 2014(4):CD010189

  6. Lee JM et al (2021) Treatment outcomes of pediatric acute myeloid leukemia in the yeungnam region: a multicenter retrospective study of the study alliance of yeungnam pediatric hematology–oncology (sayph). Children 8(2):109

  7. Hyakuna N et al (2019) Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial. Pediatr Blood Cancer 66:1–9

    Google Scholar 

  8. Klusmann JH et al (2012) The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: Results from the AML-BFM 98 study. Haematologica 97:21–29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gamis AS et al (2014) Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: Results from the randomized phase iII children’s oncology group Trial AAML0531. J Clin Oncol 32:3021–3032. https://doi.org/10.1200/JCO.2014.55.3628

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dufort Y Alvarez G et al (2020) Treatment of childhood acute myeloid leukemia in Uruguay: results of 2 consecutive protocols over 20 years. J Pediatr Hematol Oncol 42:359–366

    Article  PubMed  Google Scholar 

  11. Pession A et al (2013) Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. Blood 122:170–178

    Article  CAS  PubMed  Google Scholar 

  12. Locatelli F et al (2015) Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002 / 01 study This article has been corrected since Advance Online Publication and an erratum is also printed in. Bone Marrow Transplant 181-188. https://doi.org/10.1038/bmt.2014.246

  13. Tsukimoto I et al (2009) Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese childhood AML cooperative study group. J Clin Oncol 27:4007–4013

    Article  CAS  PubMed  Google Scholar 

  14. Kelly MJ et al (2014) Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Pediatr Blood Cancer 61:269–275

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Oncology and Hematology Unit “Lalla Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy

    Riccardo Masetti, Edoardo Muratore & Arcangelo Prete

  2. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy

    Davide Gori

  3. Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatric Bambino Gesù, Sapienza, University of Rome, Rome, Italy

    Franco Locatelli

Authors
  1. Riccardo Masetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edoardo Muratore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Davide Gori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arcangelo Prete
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franco Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edoardo Muratore.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masetti, R., Muratore, E., Gori, D. et al. Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data. Ann Hematol 102, 2267–2270 (2023). https://doi.org/10.1007/s00277-023-05219-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05219-0

Search

Navigation